نتایج جستجو برای: leukemic stem cell

تعداد نتایج: 1811685  

Journal: :Blood 2009
Roberto M Lemoli Valentina Salvestrini Elisa Bianchi Francesco Bertolini Miriam Fogli Marilina Amabile Agostino Tafuri Simona Salati Roberta Zini Nicoletta Testoni Cristina Rabascio Lara Rossi Ines Martin-Padura Fausto Castagnetti Paola Marighetti Giovanni Martinelli Michele Baccarani Sergio Ferrari Rossella Manfredini

We show the molecular and functional characterization of a novel population of lineage-negative CD34-negative (Lin(-)CD34(-)) hematopoietic stem cells from chronic myelogenous leukemia (CML) patients at diagnosis. Molecular karyotyping and quantitative analysis of BCR-ABL transcript demonstrated that approximately one-third of CD34(-) cells are leukemic. CML Lin(-)CD34(-) cells showed kinetic q...

Journal: :Blood 2017
Cécile Naudin Aurore Hattabi Fabio Michelet Ayda Miri-Nezhad Aissa Benyoucef Françoise Pflumio François Guillonneau Serge Fichelson Isabelle Vigon Isabelle Dusanter-Fourt Evelyne Lauret

RNA-binding proteins (RBPs) have emerged as important regulators of invertebrate adult stem cells, but their activities remain poorly appreciated in mammals. Using a short hairpin RNA strategy, we demonstrate here that the 2 mammalian RBPs, PUMILIO (PUM)1 and PUM2, members of the PUF family of posttranscriptional regulators, are essential for hematopoietic stem/progenitor cell (HSPC) proliferat...

2017
L H Xie M Biondo S J Busfield A Arruda X Yang G Vairo M D Minden

Despite the heterogeneity of acute myeloid leukemia (AML), overexpression of the interleukin-3 receptor-α (CD123) on both the more differentiated leukemic blast and leukemic stem cells (LSCs) provides a therapeutic target for antibody treatment. Here we present data on the potential clinical activity of the monoclonal antibody CSL362, which binds to CD123 with high affinity. We first validated ...

Journal: :Blood 2009
Ye Ding Yuka Harada Jun Imagawa Akiro Kimura Hironori Harada

Myeloproliferative neoplasms (MPNs) are clonal hematopoietic stem cell disorders characterized by proliferation of one or more myeloid cell lineages. Some patients exhibit leukemic transformation (LT) by unknown mechanisms, and chemotherapy may increase the risk of LT. To clarify the molecular mechanisms of LT, gene alterations involved in LT from patients in the chronic phase (CP) of MPNs were...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2017
Yu-Jun Dai Yue-Ying Wang Jin-Yan Huang Li Xia Xiao-Dong Shi Jie Xu Jing Lu Xian-Bin Su Ying Yang Wei-Na Zhang Pan-Pan Wang Song-Fang Wu Ting Huang Jian-Qing Mi Ze-Guang Han Zhu Chen Sai-Juan Chen

DNMT3A is frequently mutated in acute myeloid leukemia (AML). To explore the features of human AML with the hotspot DNMT3A R882H mutation, we generated Dnmt3a R878H conditional knockin mice, which developed AML with enlarged Lin-Sca1+cKit+ cell compartments. The transcriptome and DNA methylation profiling of bulk leukemic cells and the single-cell RNA sequencing of leukemic stem/progenitor cell...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2006
Branimir I Sikic

The article by Raaijmakers et al. (1) in this issue reports a provocative study with important implications for therapeutic strategies in acute myelogenous leukemia (AML). Expression of the MDR1 (ABCB1) gene, encoding the multidrug transporter P-glycoprotein (P-gp), is a major negative prognostic factor in adult patients with AMLs (2–4). Attempts to improve clinical outcomes in AML by modulatio...

Journal: :Blood 1991
H Kodama M Iizuka T Tomiyama K Yoshida M Seki T Suda S Nishikawa

Some mouse myeloid leukemias induced by X-irradiation and serially transplanted into syngenic mice do not proliferate in vitro even in the presence of hematopoietic factors. To examine whether such leukemic cells can proliferate in response to stromal cells, we cocultured them with MC3T3-G2/PA6 (PA6) preadipocytes, cells that can support the growth of hematopoietic stem cells. All leukemias dev...

Journal: :The Journal of clinical investigation 2016
Bin Zhang Ling Li Yinwei Ho Min Li Guido Marcucci Wei Tong Ravi Bhatia

Chronic myelogenous leukemia (CML) results from transformation of a long-term hematopoietic stem cell (LTHSC) by expression of the BCR-ABL fusion gene. However, BCR-ABL-expressing LTHSCs are heterogeneous in their capacity as leukemic stem cells (LSCs). Although discrepancies in proliferative, self-renewal, and differentiation properties of normal LTHSCs are being increasingly recognized, the m...

Journal: :Cancer control : journal of the Moffitt Cancer Center 2004
Monica L Guzman Craig T Jordan

BACKGROUND Malignant stem cells have been identified in acute myelogenous leukemia, chronic myeloid leukemia, and some types of acute lymphoblastic leukemia. Like normal stem cells, these leukemic stem cells (LSCs) are able to self-renew, differentiate, and proliferate extensively. Evidence suggests that LSCs are critical for the initiation and perpetuation of leukemic disease. METHODS We rev...

Journal: :Blood 2001
M L Guzman S J Neering D Upchurch B Grimes D S Howard D A Rizzieri S M Luger C T Jordan

Human acute myelogenous leukemia (AML) is thought to arise from a rare population of malignant stem cells. Cells of this nature, herein referred to as leukemic stem cells (LSCs), have been documented for nearly all AML subtypes and appear to fulfill the criteria for stem cells in that they are self-renewing and give rise to the cells found in many leukemic populations. Because these cells are l...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید